Long-acting analogues of GIP with significantly improved antihyperglycaemic and insulinotropic properties: N-terminal modification versus mid-chain acylation

Autoria(s): Irwin, N.; Clarke, G.C.; Gault, V.A.; Green, Brian; Harriott, Patrick; O'Harte, F.P.M.; Flatt, P.R.
Data(s)

2006
Identificador

http://pure.qub.ac.uk/portal/en/publications/longacting-analogues-of-gip-with-significantly-improved-antihyperglycaemic-and-insulinotropic-properties-nterminal-modification-versus-midchain-acylation(6f929bde-093b-4aa6-a972-bbc41b21bc0c).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Irwin , N , Clarke , G C , Gault , V A , Green , B , Harriott , P , O'Harte , F P M & Flatt , P R 2006 , ' Long-acting analogues of GIP with significantly improved antihyperglycaemic and insulinotropic properties: N-terminal modification versus mid-chain acylation ' Diabetologia , vol 49 , no. S1 , pp. 109-110 .
Tipo

article
Acesso ao item digital